| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 03/11/2004 | US20040048847 Increasing the sugar-transporting capacity; preventing and/or treating diabetes, diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic macroangiopathy, impaired glucose tolerance or adiposis |
| 03/11/2004 | CA2495144A1 Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
| 03/10/2004 | EP1395570A1 Oxazin(thi)one compounds used as fungicides |
| 03/10/2004 | EP1054673B1 Benzoxazine compounds for enhancing synaptic response |
| 03/10/2004 | CN1481365A Cyclization process step in making of quinolones and naphthyridines |
| 03/09/2004 | US6703404 Nitric oxide synthase inhibitors |
| 03/09/2004 | US6703402 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 03/04/2004 | WO2004019283A2 Methods for regulating transcription by targeting quadruplex dna |
| 03/04/2004 | WO2003032916A3 Organosulfur inhibitors of tyrosine phosphatases |
| 03/04/2004 | US20040044212 (Dihydro) Isoquinoline derivatives as phosphodiesterase inhibitors |
| 03/04/2004 | US20040044018 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 03/04/2004 | US20040044013 Antiarthritic agents; side effect reduction |
| 03/04/2004 | US20040043991 Antiarthritic agents; anticancer agents; antiinflammatory agents |
| 03/04/2004 | US20040043987 Novel compounds and their use as positive AMPA receptor modulators |
| 03/04/2004 | US20040043984 3,4-Dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 03/04/2004 | DE10239042A1 New fused macrocyclic pyrimidine derivatives, useful as e.g. cyclin-dependent kinase inhibitors for treating e.g. cancer, autoimmune, cardiovascular or neurodegenerative diseases or viral infections |
| 03/04/2004 | CA2496303A1 Methods for regulating transcription by targeting quadruplex dna |
| 03/03/2004 | EP1394162A1 Intermediates of azole antifungal agents and processes for the preparation thereof |
| 03/03/2004 | EP1394142A1 Carboxylic acid intermediates of antifungal agents and processes for the preparation thereof |
| 03/03/2004 | EP1392664A1 Epothilone derivatives |
| 03/03/2004 | EP1392294A1 7,8-fused 4$i(h)-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/03/2004 | EP1392283A1 Substituted coumarins and quinolines as caspases activators |
| 03/03/2004 | EP1392280A2 Arylsulfonamide ethers, and methods of use thereof |
| 03/03/2004 | CN1479742A Process for preparing substance GM-95 |
| 03/03/2004 | CN1479724A Pyridione derivatives for tretment of atherosclerosis |
| 03/03/2004 | CN1478781A Preparation method of prolisaxin |
| 03/03/2004 | CN1478778A 抗真菌剂及其制备方法和中间体 Antifungal agent and its preparation method and intermediates |
| 03/03/2004 | CN1140269C Bicyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |
| 03/02/2004 | US6699852 Substituted pyridoindoles as serotonin agonists and antagonists |
| 03/02/2004 | CA2138289C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 02/26/2004 | WO2004016287A1 Remedies for schizophrenia |
| 02/26/2004 | US20040039035 A (Ar1-X-Ar2) compound, where Ar1 and Ar2= aryl, heteroaryl or fused arylheteroaryl, X= secondary or tertiary amine, -C(=O)S, -CH=CHSO2 and -SO2N(R)2, and R=H or alkyl, useful for treating contact hypersensitivity |
| 02/26/2004 | US20040039012 Nitrogen compounds such as Benzyl-8-methyl-5,7-dioxo-1,5,6,7-tetrahydro-(1,2,4)triazolo(1,5-a)pyridine -2-carboxylic acid benzylamide, used for prophylaxis of arthritis, inflammation or cancer |
| 02/26/2004 | US20040038998 Aminopiperidine quinolines and their azaisosteric analogues with antibacterical activity |
| 02/26/2004 | US20040038994 Pyrimidine fused bicyclic metalloproteinase inhibitors |
| 02/26/2004 | US20040038978 Chemical compounds |
| 02/26/2004 | US20040038976 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
| 02/26/2004 | US20040038975 Effective against a broad range of pathogenic microorganisms with advantages in low susceptibility to microbial resistance, reduced toxicity, and improved pharmacology. |
| 02/26/2004 | US20040038857 Treating the cell with a cholinergic agonist in an amount sufficient to decrease the amount of the proinflammatory cytokine that is released from the cell, wherein the cell is a macrophage |
| 02/25/2004 | EP1391461A1 Bicyclic lactam inhibitors of interleukin-1-beta converting enzyme |
| 02/25/2004 | CN1478094A Process and ester derivatives for preparing cephalosporins |
| 02/25/2004 | CN1478080A Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/24/2004 | US6696473 Heterocyclic modulators of nuclear receptors |
| 02/24/2004 | US6696456 Carbocyclic acids and salts such as (2s,3r)-3-ethylsulfanyl-2-(4'-fluoro-biphenyl-4-sulfonylamino)-3- phenylpropionic acid, used as metalloenzyme antagonists for the prophylaxis of degenerative joint disease and as wound healing agents |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/24/2004 | US6696443 Piperidine/piperazine-type inhibitors of p38 kinase |
| 02/24/2004 | US6696441 Inhibition of p53-induced stress response |
| 02/19/2004 | WO2004015131A2 Hepatitis c virus assays |
| 02/19/2004 | WO2004014923A1 Pyrimidinone fused bicyclic metalloproteinase inhibitors |
| 02/19/2004 | WO2004014922A1 3-(carbonyl) 1h-indazole compounds as cyclin dependent kinases (cdk) inhibitors |
| 02/19/2004 | WO2004014916A1 Pyrimidine fused bicyclic metalloproteinase inhibitors |
| 02/19/2004 | WO2004014915A1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 02/19/2004 | WO2004014908A1 Heterobicylcic metalloproteinase inhibitors |
| 02/19/2004 | WO2004014900A1 Benzimidazoles and benzothiazoles as inhibitors of map kinase |
| 02/19/2004 | WO2004014895A1 Piperazine substituted aryl benzodiazepines |
| 02/19/2004 | WO2004014893A2 Antimicrobial aza-bicyclic derivates, their compositions and uses |
| 02/19/2004 | WO2004014852A2 Iminothiazolidinones as inhibitors of hcv replication |
| 02/19/2004 | WO2004014851A2 Tyrosine kinase inhibitors |
| 02/19/2004 | WO2004014389A1 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014375A2 Fused bicyclic metalloproteinase inhibitors |
| 02/19/2004 | WO2004014361A1 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 02/19/2004 | WO2004014354A1 1,6-fused uracil derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014313A2 Combination pharmaceutical agents as inhibitors of hcv replication |
| 02/19/2004 | WO2003086306A3 5ht2c receptor modulators |
| 02/19/2004 | WO2003060078A9 Heterocyclic modulators of nuclear receptors |
| 02/19/2004 | US20040034078 Such as 2-(2-butylamino-ethylsulfanylmethyl)-1H-benzimidazole-4-carboxylic acid amide for treatment of cancer, strokes, head trauma, and neurodengenerative diseases; solid phase synthesis |
| 02/19/2004 | US20040034061 An antagonist of corticotropin releasing factor receptor, treating depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastrointestinal disorders, drug dependence |
| 02/19/2004 | US20040034054 Fused bicyclic metalloproteinase inhibitors |
| 02/19/2004 | US20040034021 Intravenous rifalazil formulation and methods of use thereof |
| 02/19/2004 | US20040034015 Administering to a human patient suffering from addictive behavior associated with 5HT2C receptor modulation, a fused tetra or pentaheterocyclic compound containing nitrogen in the rings |
| 02/19/2004 | US20040034009 1,6-Fused uracil derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | CA2493146A1 Antimicrobial aza-bicyclic derivates, their compositions and uses |
| 02/19/2004 | CA2492837A1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 02/18/2004 | EP1389189A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 02/18/2004 | EP0944627B1 8-azabicyclo 3.2.1]octane-, 8-azabicyclo 3.2.1]oct-6-ene-, 9-azabicyclo 3.3.1]nonane-, 9-aza-3-oxabicyclo 3.3.1]nonane- and 9-aza-3-thiabicyclo 3.3.1]nonane derivatives, their preparation and their use as insecticides |
| 02/18/2004 | CN1476442A Pyridine derivatives with IKB-kinase (IKK-beta) INhibiting activity |
| 02/18/2004 | CN1138760C Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 02/17/2004 | US6693105 Using xanthinyl derivatives to reduce treatment induced toxicity; inhibiting cellular signaling through second messenger pathway; reducing cellular level of nonarachi-donate phosphatidic acid and diacylglycerol |
| 02/12/2004 | WO2004013148A1 Novel 4-hydroxy-2h-thieno[2,3-e]-1,2-thiazine-3-carboxamide-1,1-dioxides, methods for the production thereof and medicaments containing the same |
| 02/12/2004 | WO2004013147A1 Racemization and enantiomer separation of clopidogrel |
| 02/12/2004 | WO2004013141A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 02/12/2004 | WO2004012684A2 M3muscarinic acetylcholine receptor antagonists |
| 02/12/2004 | WO2003090672A3 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 02/12/2004 | US20040029937 Benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 02/12/2004 | US20040029882 Antimicrobial quinolones, their compositions and uses |
| 02/12/2004 | US20040029867 Anticoagulants; cardiovascular disorders |
| 02/12/2004 | US20040029862 Alzheimer's disease |
| 02/12/2004 | US20040029720 Supported group 8-10 transition metal olefin polymerization catalysts |
| 02/12/2004 | US20040028943 Electroluminescence |
| 02/12/2004 | CA2494421A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 02/11/2004 | EP1387842A1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 02/11/2004 | CN1474812A (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitor |
| 02/11/2004 | CN1474803A Novel amide derivatives and medicinal use thereof |
| 02/10/2004 | US6689883 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 02/05/2004 | WO2004011466A1 NOVEL PROCESS FOR PRODUCING IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVE |
| 02/05/2004 | WO2004011460A2 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents |
| 02/05/2004 | US20040024045 Glucagon antagonists/inverse agonists |
| 02/05/2004 | US20040024012 Crystallization/precipitation of clopidogrel-camphorsulfonic acid salts in hydrocarbon solvent; catalytic isomerizaion; for treatment of atherosclerosis |
| 02/05/2004 | US20040024011 Racemization and enantiomer separation of clopidogrel |
| 02/05/2004 | US20040023953 The invention relates to mercaptomethyl-substituted thiazolo(2,3- b)quinazolines, oxazolo(2,3-b)quinazolines and imidazolo(2,1-b) quinazolines. Matrix metalloproteinase inhibitors (MMP) and give a simple synthesis method. |